Study directory

Mental health studies with practical context.

Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.

Back to overview
1107studies shown
Showing 217-228 of 1,107
Drug study icon
RecruitingISRCTN42305247

Antidepressant Controlled study for Negative Symptoms in schizophrenia

This study is testing a medication approach for people with psychosis. Participants receive a study treatment and complete follow-up visits and assessments.

In United Kingdom
SchizophreniaOtherFrom 18 Years to 65 Years
Countries
United Kingdom
Sponsor
Imperial College London (UK)
Condition
Schizophrenia
Drug study icon
RecruitingISRCTN12682719

Antidepressant for the prevention of depression following first-episode psychosis

This study is looking at whether a digital support tool can help people with First Episode Psychosis, Mental and Behavioural Disorders, or Unspecified nonorganic psychosis. Participants receive a study treatment and complete follow-up visits and assessments.

In United Kingdom
Depression, SchizophreniaOtherFrom 18 Years to 65 Years
Countries
United Kingdom
Sponsor
University of Birmingham
Condition
Depression, Schizophrenia
Drug study icon
RecruitingISRCTN15969819

Antidepressants to prevent relapse in depression

This study is looking at whether a digital support tool can help people with Depression or Mental and Behavioural Disorders. Participants receive a study treatment and complete follow-up visits and assessments.

In United Kingdom
DepressionOtherFrom 18 Years to 74 Years
Countries
United Kingdom
Sponsor
PRIMENT CTU, University College London
Condition
Depression
Drug study icon
RecruitingISRCTN45338259

Antiglucocorticoid augmentation of antiDepressants in Depression: the ADD study

This study is testing a medication approach for people with Major depression, Mental and Behavioural Disorders, or Depression. Participants receive a study treatment and complete follow-up visits and assessments.

In United Kingdom
DepressionOtherFrom 18 Years to 65 Years
Countries
United Kingdom
Sponsor
Northumberland, Tyne and Wear NHS Foundation Trust (UK)
Condition
Depression
Drug study icon
RecruitingISRCTN13280178

Antipsychotic medication and weight gain: effects of neuromodulation and cognitive training

This study is testing a medication approach for people with Weight gain in taking antipsychotic medication for schizophrenia or schizoaffective disorder or Signs and Symptoms. Participants receive a study treatment and complete follow-up visits and assessments.

In United Kingdom
SchizophreniaOtherFrom 18 Years to 65 Years
Countries
United Kingdom
Sponsor
King's College London
Condition
Schizophrenia
Other study type icon
RecruitingISRCTN27139591

Are the psychoto-mimetic effects of cannabis mediated via dopamine?

This study is looking at whether 1 can help people with Mental and Behavioural Disorders: Psychosis, Mental and Behavioural Disorders, or Psychosis. Participants receive a study treatment and complete follow-up visits and assessments.

In United Kingdom
SchizophreniaOther
Countries
United Kingdom
Sponsor
Record Provided by the NHSTCT Register - 2007 Update - Department of Health
Condition
Schizophrenia
Behavioral study icon
RecruitingISRCTN14659858

Are the short-term benefits of two brief mindfulness interventions sustained?

This study is looking at whether an online mindfulness program can help people with Anxiety, depression and stress, Mental and Behavioural Disorders, or Anxiety, depression, stress. Participants take part in an online mindfulness program and complete follow-up assessments.

Remote / online
Anxiety, DepressionOtherFrom 18 Years to 65 Years
Countries
United Kingdom
Sponsor
Royal Holloway, University of London
Condition
Anxiety, Depression
Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.